Can exposure-based CBT extend the effects of intravenous ketamine in obsessive-compulsive disorder? an open-label trial
about
Ketamine and Beyond: Investigations into the Potential of Glutamatergic Agents to Treat Depression.Glutamate-modulating drugs as a potential therapeutic strategy in obsessive-compulsive disorder.Effect of a Novel NMDA Receptor Modulator, Rapastinel (Formerly GLYX-13), in OCD: Proof of Concept.Intranasal Ketamine and Cognitive-Behavioral Therapy for Treatment-Refractory Obsessive-Compulsive Disorder.Psychedelic-Assisted Psychotherapy: A Paradigm Shift in Psychiatric Research and Development
P2860
Can exposure-based CBT extend the effects of intravenous ketamine in obsessive-compulsive disorder? an open-label trial
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Can exposure-based CBT extend ...... disorder? an open-label trial
@en
type
label
Can exposure-based CBT extend ...... disorder? an open-label trial
@en
prefLabel
Can exposure-based CBT extend ...... disorder? an open-label trial
@en
P2093
P2860
P50
P356
P1476
Can exposure-based CBT extend ...... disorder? an open-label trial
@en
P2093
Danae Sonnenfeld
Helen Blair Simpson
Jordana Zwerling
P2860
P304
P356
10.4088/JCP.15L10138
P577
2016-03-01T00:00:00Z